BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to Medicare Part D redesign, rebate reform and international pricing index (including H.R. 3, H.R. 19) Medicaid Drug Rebate Program (MDRP), including value-based purchasing (VBP) arrangements and line extensions Issues related to Biosimilars
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHARINE TROLLER BOND | — |
| JULIAN MALASI | — |
| SARAH ELIZABETH NORDSTROM | — |
| MARY BRIDGET WALSH | — |
Animals ANI
Issues related to Animal Health Issues related to Veterinary Telehealth Issues related to Rural Broadband Issues related to One Health Issues related to Pesticide Registration Improvement Act and issues related to compounding
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT BENNETT | — |
| BILL DAVIS | — |
| MARY BRIDGET WALSH | — |
Trade (domestic/foreign) TRD
Prescription drug manufacturing and supply chains
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHARINE TROLLER BOND | — |
| BILL DAVIS | — |
| JULIAN MALASI | — |
| SARAH ELIZABETH NORDSTROM | — |
| MARY BRIDGET WALSH | — |
Budget/Appropriations BUD
Issues related to FY 2022 Appropriations S. 2599, Rural Development, Food and Drug Administration Related Agencies Appropriations Act 2022
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT BENNETT | — |
| KATHARINE TROLLER BOND | — |
| BILL DAVIS | — |
| JULIAN MALASI | — |
| SARAH ELIZABETH NORDSTROM | — |
| MARY BRIDGET WALSH | — |
Defense DEF
Issues Related to National Defense Authorization Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT BENNETT | — |
| BILL DAVIS | — |
| MARY BRIDGET WALSH | — |
Health Issues HCR
Issues related to prescription drug pricing and value Issues related to ICD-10 diagnosis codes Prescription drug manufacturing and supply chains Issues regarding the ongoing COVID-19 public health emergency Issues related to Biosimilars (including H.R. 7047) Issues related to the 340B program Issues related to tax Issues related to reauthorizing the Prescription Drug and Biosimilar User Fee Agreements Issues related to Intellectual Property Issues related to Inflation Reduction Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHARINE TROLLER BOND | — |
| JULIAN MALASI | — |
| SARAH ELIZABETH NORDSTROM | — |
| MARY BRIDGET WALSH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.